Reaction
High Density Lipoprotein Increased reporting signals
As of the last recalculation, High Density Lipoprotein Increased appears in 973 FAERS reports alongside 10 co-occurring drug terms. The strongest observed disproportionality signal is INCLISIRAN (PRR 91.1).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Inclisiran | 33 | 91.1 | 91.5 |
| Alirocumab | 23 | 20.1 | 20.1 |
| Fingolimod Hcl | 70 | 18.6 | 18.6 |
| Tenofovir Disoproxil Fumarate Tablets | 5 | 12.4 | 12.5 |
| Evolocumab | 66 | 9.3 | 9.3 |
| Asfotase Alfa | 4 | 8.6 | 8.6 |
| Isotretinoin | 13 | 5.7 | 5.7 |
| Apalutamide | 3 | 5.5 | 5.5 |
| Romosozumab-Aqqg | 3 | 4.7 | 4.7 |
| Relugolix | 4 | 3.6 | 3.6 |